Keywords: COVID-19 Pandemic, Healthcare, Ripple Effect, Mental Health, Antimicrobial Resistance (AMR), Antimicrobial Stewardship Programs (ASP), Addictions, Substance Use Disorders (SUD’s)


The COVID-19 Pandemic has disrupted life and changed what we knew as normal, for the past 9 months. Although the first case of COVID-19 was identified in Wuhan, China in mid-December 2019, it was coined as a Pandemic by WHO in March 2020. The COVID-19 Pandemic has impacted each and everyone and caused a ripple effect in all areas of life, the healthcare is no exception. With its novel nature, limited information, lack of resources, risky working conditions, and high spikes in cases, it has caused a massive overload on the healthcare systems. It has caused mental health disturbances not just in the frontline workers and COVID-19 survivors but also in the general public owing to uncertainty, isolation, fear, anxiety, and
misinformation. In addition to this, there has also been an increase in the prescription of antibiotics which stems from the inability to examine the patient physically and obtain samples for cultures as consultations are scheduled through telemedicine. Antimicrobial resistance(AMR) is considered to be further potentiated during the Pandemic as Antimicrobial stewardship programs (ASP) have been disrupted and there is an increase in hospital admissions and intubations of patients. Measures like lockdown and travel restrictions placed to curb the spread of the virus have negatively impacted individuals with addictions and substance use disorders (SUD’s) due to inability to access de-addiction centers, increased isolation, and inability to obtain toxicants which lead to the use of adulterated substances and in some cases withdrawal symptoms. The lockdown has also caused delays in the treatment of chronic and co-morbid diseases like Diabetes, Cardiovascular diseases, Cancer, Dialysis leading to poor disease management and progression of the disease. It has also impacted regular vaccination schedules and periodic health checkups leading to late diagnosis of diseases.


COVID-19: The Hidden Impact on Mental Health and Drug Addiction- Stefania Chiappini1*, Amira Guirguis1,2*, Ann John2, John Martin Corkery1, and Fabrizio Schifano1- Front. Psychiatry, 29 July 2020.

Mental health survey of medical staff in a tertiary infectious disease hospital for COVID-19-Huang JZ1, Han MF1, Luo TD1, Ren AK1, Zhou XP1 - Chinese Journal of Industrial Hygiene and Occupational Diseases, 04 Mar 2020, 38(3):192-195

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors - Mario Gennaro Mazzaa, Rebecca De Lorenzo, Caterina Conte, Sara Poletti, Benedetta Vai , Irene Bollettini , Elisa Maria Teresa Melloni , Roberto Furlan, Fabio Ciceri, Patrizia Rovere-Querini , and the COVID-19 BioB Outpatient Clinic Study group, Francesco Benedettia

Petterson S, Westfall J, Miller BF. Projected Deaths of Despair During the Coronavirus Recession. Well, Being Trust (2020) 8:2020.

Mental Health and the Covid-19 Pandemic-Betty Pfefferbaum, M.D., J.D., Carol S. North, M.D., M.P.E.- The New England Journal of Medicine-August 06,2020.

Antimicrobial resistance – World Health Organization

How covid-19 is accelerating the threat of antimicrobial resistance- Jeremy Hsu-BMJ 2020

Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing- Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. -Clin Infect Dis. 2020 May 2; ciaa530.

Clinical management of COVID-19 Interim Guidance - May 2020. Geneva: World Health Organization; 2020.

Tackling antimicrobial resistance in the COVID-19 pandemic - Haileyesus Getahun a, Ingrid Smith a, Kavita Trivedi a, Sarah Paulin a & Hanan H Balkhy b -Bulletin of the World Health Organization 2020

Microbial strategies to reduce pathogens and drug resistance in clinical settings- Caselli E. Hygiene- Microb Biotechnol. 2017

Biocidal agents used for disinfection can enhance antibiotic resistance in gram-negative species- Kampf G - Antibiotics (Basel). 2018 Dec 1

The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance - Aimee K. Murray* -Front. Microbiol., 13 May 2020

Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs - Hasti Mazdeyasna & Priya Nori & Payal Patel & Michelle Doll & Emily Godbout & Kimberly Lee & Andrew J. Noda & Gonzalo Bearman & Michael P. Stevens - Current Infectious Disease Reports (2020)

COVID-19 and addiction - Mahua Jana Dubey, Ritwik Ghosh, Subham Chatterjee, Payel Biswas, Subhankar Chatterjee, Souvik Dubey - Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Collision of the COVID-19 and Addiction Epidemics- Nora D.Volkow- Annals of Internal Medicine

The Invisible Epidemic: Neglected Chronic Disease Management During COVID-19- Adam Wright PhD1, Alejandra Salazar PharmD2, Maria Miric PhD2, Lynn A. Volk MHS3, Gordon D. Schiff MD2- J Gen Intern Med 35(9):2816–7 DOI:

Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020- Mark É. Czeisler - Weekly / September 11, 2020, / 69(36);1250–1257- CDC. DOI:

How to Cite
Sahar, A. N. (2020). THE RIPPLE EFFECT OF COVID-19 PANDEMIC IN HEALTHCARE. International Journal of Research -GRANTHAALAYAH, 8(12), 30-35.